Simplex Trading’s Palvella Therapeutics PVLA Stock Holding History

Simplex Trading’s Portfolio PVLA Stock Details PVLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$37.4K	Buy	+300	New	+$31.3K	﹤0.01%	6166
2025 Q2	–	Sell	-100	Closed	-$2K	–	9966
2025 Q1	$2K	Buy	+100	New	+$1.93K	﹤0.01%	8119
2023 Q1	–	Sell	-21	Closed	-$1K	–	10338
2022 Q4	$1K	Hold	21	–	–	﹤0.01%	8970
2022 Q3	$1K	Sell	21 -14	-40%	-$1.8K	﹤0.01%	9692
2022 Q2	$5K	Sell	35 -4	-10%	-$730	﹤0.01%	8882
2022 Q1	$9K	Sell	39 -22	-36%	-$5.78K	﹤0.01%	8997
2021 Q4	$18K	Sell	61 -409	-87%	-$131K	﹤0.01%	8505
2021 Q3	$145K	Buy	470 +1	+0.2%	+$348	﹤0.01%	6092
2021 Q2	$143K	Buy	+469	New	+$103K	﹤0.01%	6211
2020 Q4	–	Hold	0	–	-$6K	–	9218
2020 Q3	–	Hold	0	–	–	–	7063
2019 Q4	–	Sell	-1	Closed	-$37K	–	8093
2019 Q3	$37K	Buy	+1	New	+$387	﹤0.01%	5312

Other funds holding PVLA

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Simplex Trading's PVLA Position: Q1 2026 in Review

Simplex Trading opened a new position in Palvella Therapeutics (PVLA) in Q1 2026: 1,622 shares worth $202K. The stake represents ﹤0.01% of the portfolio and ranks #4282 among its holdings. This is a return to the name: Simplex Trading previously reported a position in PVLA as recently as Q4 2022.

Simplex Trading first reported a position in PVLA in Q1 2018 and has held it in 12 quarters since. 180 funds tracked by Wall St. Rank hold PVLA as of Q1 2026.

Simplex Trading held 1,622 shares of Palvella Therapeutics worth $202K as of Q1 2026.
Palvella Therapeutics was a new Simplex Trading position in Q1 2026.
Palvella Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4282 holding.
Simplex Trading first reported a position in Palvella Therapeutics in Q1 2018 and has held it in 12 quarters since.
180 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.